Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer-Reference-Cited by-同舟云学术

Evaluation of PD-L1 expression on vortex-isolated circulating tumor cells in metastatic lung cancer

Published:2018-02-07 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Dhar Manjima,Wong Jessica,Che James,Matsumoto Melissa,Grogan Tristan,Elashoff David,Garon Edward B.,Goldman Jonathan W.,Sollier Christen Elodie,Di Carlo Dino,Kulkarni Rajan P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-19245-w.pdf

Reference27 articles.

1. Verdegaal, E. M. et al. Neoantigen landscape dynamics during human melanoma-T cell interactions. Nature (2016).

2. van Rooij, N. et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J Clin Oncol 31, e439–442 (2013).

3. Topalian, S. L., Taube, J. M., Anders, R. A. & Pardoll, D. M. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 16, 275–287 (2016).

4. Ribas, A. Tumor immunotherapy directed at PD-1. N Engl J Med 366, 2517–2519 (2012).

5. Ribas, A. Adaptive Immune Resistance: How Cancer Protects from Immune Attack. Cancer Discov 5, 915–919 (2015).

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis;Frontiers in Immunology;2024-06-10

3. Engineered immunologic niche monitors checkpoint blockade response and probes mechanisms of resistance;ImmunoMedicine;2024-06

4. Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics;Proceedings of the National Academy of Sciences;2024-04-29

5. Fiber-Optic Biosensors for Cancer Theranostics: From in Vitro to in Vivo;Photonic Sensors;2024-04